StockData
NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30

NEUROONE MEDICAL TECHNOLOGIES Corp

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.00+0.04 (+4.01%)

Close on Oct 19, 2026

Market cap
$8.74M
P/E (TTM)
–
Dividend yield
–

NEUROONE MEDICAL TECHNOLOGIES Corp revenue by segment

No segment breakdown reported

Neuroone Medical Technologies does not break out revenue by segment, region or product in the tagged data of its filings for this period type.